LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	AZD 5438	3.33	uM	LJP6	3	J02	72	hr	1334	934	3970	0.2352	-0.1520
BT-20	AZD8055	3.33	uM	LJP6	2	A08	72	hr	1334	1537	3970	0.3871	0.0767
BT-20	Alvocidib	3.33	uM	LJP6	1	A14	72	hr	1334	405	3970	0.1020	-0.3527
BT-20	AZD 5438	3.33	uM	LJP6	2	J02	72	hr	1334	984	3970	0.2478	-0.1330
BT-20	AZD7762	3.33	uM	LJP6	1	L02	72	hr	1334	1448	3970	0.3647	0.0430
BT-20	AZD8055	3.33	uM	LJP6	1	A08	72	hr	1334	1237	3970	0.3115	-0.0371
BT-20	Afatinib	3.33	uM	LJP6	3	G20	72	hr	1334	3133	3970	0.7890	0.6822
BT-20	Sigma A6730	3.33	uM	LJP5	3	B20	72	hr	1334	3866	3970	0.9736	0.9602
BT-20	AT-7519	3.33	uM	LJP6	1	K02	72	hr	1334	254	3970	0.0640	-0.4099
BT-20	AZD 5438	3.33	uM	LJP6	1	J02	72	hr	1334	1139	3970	0.2868	-0.0742
BT-20	AZD-6482	3.33	uM	LJP5	2	I02	72	hr	1334	2047	3970	0.5155	0.2702
BT-20	AZD-6482	3.33	uM	LJP5	3	I02	72	hr	1334	2074	3970	0.5223	0.2805
BT-20	AZD7762	3.33	uM	LJP6	2	L02	72	hr	1334	1361	3970	0.3427	0.0100
BT-20	AZD7762	3.33	uM	LJP6	3	L02	72	hr	1334	1507	3970	0.3795	0.0654
BT-20	Afatinib	3.33	uM	LJP6	1	G20	72	hr	1334	3554	3970	0.8950	0.8419
BT-20	Afatinib	3.33	uM	LJP6	2	G20	72	hr	1334	3446	3970	0.8678	0.8009
BT-20	Sigma A6730	3.33	uM	LJP5	1	B20	72	hr	1334	3309	3970	0.8333	0.7489
BT-20	Sigma A6730	3.33	uM	LJP5	2	B20	72	hr	1334	3698	3970	0.9313	0.8965
BT-20	Alvocidib	3.33	uM	LJP6	2	A14	72	hr	1334	369	3970	0.0929	-0.3663
BT-20	Alvocidib	3.33	uM	LJP6	3	A14	72	hr	1334	319	3970	0.0803	-0.3853
BT-20	AT-7519	3.33	uM	LJP6	2	K02	72	hr	1334	388	3970	0.0977	-0.3591
BT-20	AT-7519	3.33	uM	LJP6	3	K02	72	hr	1334	410	3970	0.1033	-0.3508
BT-20	AZD-6482	3.33	uM	LJP5	1	I02	72	hr	1334	2126	3970	0.5354	0.3002
BT-20	AZD8330	3.33	uM	LJP5	1	G20	72	hr	1334	3483	3970	0.8771	0.8149
BT-20	AZD8055	3.33	uM	LJP6	3	A08	72	hr	1334	1399	3970	0.3523	0.0244

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)